O'Shaughnessy Asset Management’s FibroBiologics FBLG Stock Holding History

O'Shaughnessy Asset Management’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,020	Closed	-$80.8K	–	2414
2024 Q4	$80.8K	Buy	+2,020	New	+$108K	﹤0.01%	1878

Other funds holding FBLG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CFP

Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAS

Optivise Advisory Services Franklin, Tennessee $197M AUM 26.07% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

O'Shaughnessy Asset Management's FBLG Position: Q1 2025 in Review

O'Shaughnessy Asset Management sold out of FibroBiologics (FBLG) in Q1 2025, closing a stake of 2,020 shares — an estimated $80.8K sold.

O'Shaughnessy Asset Management first reported a position in FBLG in Q4 2024 and held it in 1 quarter. The position peaked at $80.8K in Q4 2024. 65 funds tracked by Wall St. Rank hold FBLG as of Q1 2025.

O'Shaughnessy Asset Management reported no remaining FibroBiologics position as of Q1 2025 after selling out during the quarter.
O'Shaughnessy Asset Management sold 2,020 FibroBiologics shares in Q1 2025, an estimated $80.8K.
O'Shaughnessy Asset Management first reported a position in FibroBiologics in Q4 2024 and held it in 1 quarter.
O'Shaughnessy Asset Management's FibroBiologics position peaked at $80.8K in Q4 2024.
65 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2025.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2025, filed 13 May 2025.